Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Steelcase Q1 Earnings

Steelcase (NYSE:SCS) reported its Q1 earnings results on Wednesday, June 21, 2023 at 04:05 PM. Here’s what investors…
byBenzinga Insights
June 21, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Steelcase (NYSE:SCS) reported its Q1 earnings results on Wednesday, June 21, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Steelcase beat estimated earnings by 800.0%, reporting an EPS of $0.09 versus an estimate of $0.01.

Revenue was up $11.20 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 5.99% increase in the share price the next day.

Here’s a look at Steelcase’s past performance:

Quarter Q4 2023 Q3 2023 Q2 2023 Q1 2023
EPS Estimate 0.11 0.18 0.13 -0.18
EPS Actual 0.19 0.20 0.21 -0.05
Revenue Estimate 751.37M 836.42M 885.20M 690.94M
Revenue Actual 801.70M 826.90M 863.30M 740.70M

To track all earnings releases for Steelcase visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States ‘Primary Growth Drivers’

By Jelena Martinovic
May 30, 10:09 AM
Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its first-quarter 2024 results for the three months ended March 31, 2024.The Medford, Oregon-based company reported record quarterly revenue of $6.7 million, compared to $6 million in the three months ended April 30, 2023, representing a year-over-year increase of 11%."This was another exciting quarter with record revenue and aEBITDA despite the year-ago comparison period including April instead of January; April is seasonally a stronger month for the industry," Obie Strickler, CEO of Grown Rogue, said. "In addition, we achieved record indoor revenue in Michigan and Oregon during the quarter and are thrilled that an increasing number of customers in competitive markets are choosing our products which means we are continuing to bring them value."

CSE:GRIN

Read More

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue And Provides Corporate Updates; Sees Q4 Revenue $69M-$71M Vs $68.27M Est.; FY23 Revenue $178M-$180M Vs $185.4M Est.; LIVMARLI Net Products Sales Of $141M-143M Expected For 2023

By Benzinga Newsdesk
January 8, 9:58 AM
- $186-188 million in total revenue and $178-180 million net product sales expected for 2023, preliminary and unaudited- LIVMARLI net products sales of $141-143 million expected for 2023, representing approximately 89%

MIRM